Best Agrolife's Revenue Crosses Rs. 1,700 Cr., EBITDA Margin Reaches 18%, and 30% Dividend Recommended in FY23

May 30, 2023 01:35 AM IST | By NewsVoir
 Best Agrolife's Revenue Crosses Rs. 1,700 Cr., EBITDA Margin Reaches 18%, and 30% Dividend Recommended in FY23
Image source: Kalkine Media

Best AgrolifeLimited (BAL) (BSE: 539660, NSE: BESTAGRO) today reported financial results for the Quarter and Year ended March 31st, 2023.

Commenting on results, Mr. Vimal Alawadhi, Managing Director, Best Agrolife Limited, said, "I am delighted to inform you that we have delivered strong revenue from operations of Rs. 1,746 cr. which is a robust growth of 44% over FY22. Our constant focus on introducing the innovative products to cater to farmers need has resulted in BAL introducing many specialised combination products including patented novel combination Ronfen in FY23 which drove the growth during the year. We have also expanded our margins by 427 bps during the year which was driven by change in product mix.

Best Agrolife Board has also recommended a dividend of 30% (i.e. Rs. 3 per share), which is 50% jump over last year.

Q4FY23 was difficult for the industry at large due to higher channel inventory and excess supply from China at lower prices. Best Agrolife was also affected by this as its branded product portfolio is more focused on the kharif season. The company is working towards introducing more branded products which are focused on Rabi season which will improve breadth of the portfolio and will also make the portfolio more balanced which is currently skewed more towards kharif season.

In line with its commitment to "Make in India", Best Agrolife has embarked on a capex plan to expand its technical capabilities as well as improve backward integration which will lead to lower dependence on China and better cost structure.

Overall, the company has an exciting product pipeline ready to be launched in FY24 which are in line with its strategy of introducing more patented and specialised combination products which will help continue strong growth momentum as well as improve the margins in FY24."

Key Results Highlights (FY23 Consolidated)

  • Revenue from operations for FY23 grew by 44% YoY to Rs. 1,746 cr.

  • Gross margin for the year is at 28% as compared to 19% in FY22 which was an expansion of 963 bps YoY.

  • EBITDA for the year came at Rs. 314 cr up 89% YoY compared to Rs. 166 cr in FY22.

  • EBITDA margin for the year came at 18% as compared to 14% in FY22; expansion of 427 bps YoY.

  • PAT for the year was at Rs. 192cr up 83% on YoY basis. PAT margin for the year was at 11% compared to 9% in FY22.

Key Business highlights for FY23

  • ​Products Launched during FY23

  • Launched a first-of-its-kind proprietary ternary insecticidal combination - Ronfen. Ronfen is a single-shot solution that controls all sucking pests in various crops like cotton, chilly, vegetables, and many other segments having addressable market of ~Rs. 8,000 cr.

  • Best Agro Group became the first company to launch CTPR based formulations CITIGEN & VISTARA in domestic market. This single molecule has around Rs 2,800 cr. domestic market.

  • BAL also launched niche combination products such as Tambo, Axeman, Warden and Reveal during FY23.

  • ​Approvals and Registration received

  • Seedlings India Pvt. Ltd. wholly-owned subsidiary of BAL received a patent valid for 20 years for the first-of-its-kind fungicidal composition of Cyazofamid, Dimethomorph, and Difenoconazole which is going to emerge as a highly effective crop solution against Late Blight and Downy Mildew in tomato and grapes crops respectively.The approximate market size of this fungicidal composition is Rs. 350 crore.

  • Granted registration for indigenous manufacturing of Pyroxasulfone technical u/s 9(3). The market size of Pyroxasulfone is approximately Rs. 450 Crore and is expected to grow in coming years.Until now India was dependent on other countries for Pyroxasulfone.

  • Granted registration for the indigenous manufacturing of Propiquazafop u/s 9(3).

  • Granted registration for the indigenous manufacturing of Cyhalofop-Butyl Technical, u/s 9(3).

  • Capex Update

  • Board of directors approved Capex plan of Rs. 200 cr. towards brownfield expansion in the technical manufacturing unit of Best Crop Science Private Limited (a wholly owned subsidiary of the Company).

Product Pipeline for FY24

  • BAL has pipeline of 10+ products to be launched during the course of FY24 which includes couple of patented products as well as some niche combination products and technicals.

About Best Agrolife Limited

BAL is a research-based company focused on bringing world-class and cost-effective crop solutions in the form of novel agrochemical formulations to the agricultural industry for improving crop productivity. Currently, BAL has 7,000 MTPA and 30,000 MTPA technical and formulation manufacturing capacity respectively through three of its manufacturing plants in Gajaraula, Greater Noida, and Jammu & Kashmir. It boasts to have more than 5200 distributors in lndia and it retains an unrivalled portfolio of 400+ formulations and more than 100+ technical manufacturing licenses.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.